May 15, 2006 -- Combined contrast-enhanced magnetic resonance imaging (CCE MRI) is an accurate, noninvasive method for staging liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), ...

Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...

Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in ...

LINKÖPING, Sweden--(BUSINESS WIRE)--AMRA Medical has a large presence at this year’s The Liver Meeting®. A total of nine abstracts will be presented, focusing on how AMRA’s MRI-based muscle assessment ...

Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...

Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ANN ARBOR, ...

ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care Achieved Intraclass ...